EGFR and ovarian carcinoma: For instance, for ovarian cancer, a panel made up of cancer antigen 125 (CA-125), human epididymis protein 4 (HE4), cancer antigen 19-9 (CA 19-9), epidermal growth factor receptor (EGFR), granulocyte colony-stimulating factor (G-CSF), eotaxin, interleukin-2 receptor (IL-2R), circulating vascular cell adhesion molecule-1 (cVCAM), and macrophage migration inhibiting factor (MIF) seems to exhibit a satisfactory specificity and sensitivity [10].